Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Diana Anderson

Diana Anderson

University of Bradford, UK UK

Yoshiaki Omura

Yoshiaki Omura

New York Medical College, USA USA

Michael Retsky

Michael Retsky

Harvard TH Chan School of Public Health, USA USA

Sherry A Bradford

Sherry A Bradford

AccuTheranostics, Inc., USA USA

Victor Frenkel

Victor Frenkel

University of Maryland, USA USA

Leroy J. Lowe

Leroy J. Lowe

Lancaster University, UK UK

Melvin L DePamphilis

Melvin L DePamphilis

National Institute for Child Health & Human Development, USA USA

Wassil Nowicky

Wassil Nowicky

Ukrainian Anti-Cancer Institute, Austria Austria

Cancer Therapy-2018

About Conference


Cancer Science and Therapy conference invites Cancer Specialists, Oncologists, Professors, Directors, Students and Industrial professionals from USA, Europe and Asia. Explore and learn more about Conference Series LLC: World‘s leading Event Organizer. Meet Global Oncologists, Doctors, Scientists Researchers and Industry Professionals from UK, Europe, USA, Middle East, and Asia at Cancer Therapy 2018.

26th Annual Congress on Cancer Science and Therapy
Date: October 29-30, 2018 San Francisco
, USA
Venue: 
San Francisco, USA

Cancer Therapy 2018 will be organized around the theme Securing the Future of Innovation in Cancer Treatment”.

Cancer Therapy 2018 is comprised of many interactive scientific sessions on different types of Cancer disorders as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Cancer Therapy 2018 welcomes the Cancer Specialists, Oncologists, Professors, Director’s, Research scholars, Student delegates and Industrial professionals from Biomedical and healthcare sectors to be a part of it in Cancer Therapy 2018

According to market study, annual global growth in the oncology drug market is expected to be 7.5 – 10.5 percent through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes. Payers also are expected to tighten their negotiation stance with manufacturers and adopt new payment models in an effort to drive greater value from their expenditures on these drugs.

Cancer Science and Therapy are organized Conference Series LLC which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Cancer Therapy 2018 will provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.

Why to attend?

Cancer Therapy 2018 will provide a stimulating scientific environment and a platform for the participants to share ideas and knowledge, collaborate on Cancer and Oncology related problems and network with other professionals. Discussing on various imperative topics will add an insight to ponder and confer over crux of today’s scientific and technological perk up. It will be amazing opportunity for the attendees to explore the beautiful City of Los Angeles with gaining knowledge, sure to raise insights, conflate present with future and cogitate on ideas and reality in Oncology meetings. To fight against these hard to cure cancer diseases, Cancer Therapy 2018 has taken this initiative to explore every aspects of Cancer research.

About Los Angeles City:

One of the greatest cities in the world, Los Angeles is always a whirlwind of activity, with famous sites at every turn and never enough time to see them all. L.A. has many famous sights. There are many very long beaches, such as Venice Beach. Many visitors go to Hollywood, home to the Hollywood Walk of Fame and the Mann's (Grauman's) Chinese Theatre, a large cinema. Los Angeles also has many fine museums such as the L.A. County Museum of Art and the Getty Museum. Another sight is the Los Angeles City Zoo. Los Angeles is the only major city in the world with an active population of wild mountain lions. Each of the City’s five boroughs contains its own roster of must-see destinations, great restaurants, cultural hot spots and unforgettable activities. Attractions in Los Angeles suit all tastes.

Target Audience

The 26th Annual conference on Cancer Science and Therapy is intended for Cancer Specialists, Gynecologic oncologists, Medical oncologists, Radiation oncologists, Obstetricians/gynecologists, fellows and residents, research scientists, nurses, nurse practitioners, physician assistants, allied health professionals, and others involved in the care of patients with Oncologic malignancies.

Learning Objectives

As a result of attending the Annual Conference, learners will be able to:

• Interpret contemporary research findings on the prevention of and screening for Cancerous tumours and be able to appropriately implement these findings into clinical practice;
• Examine the significance of novel approaches to the medical and surgical management of Cancerous tumours within the context of the current standard of care and be able to integrate new therapies into clinical practice in an evidence-based manner;
• Assess the implications for future research and clinical practice of new developments in translational research on Cancerous tumours
• Demonstrate improvement in competence, performance and patient outcomes; and
• Identify and explain the latest trends in global research, methods, and technology in the treatment of Cancerous tumours.

 
 

Sessions and Tracks

Cancer is a class of diseases characterized by out-of-control cell growth. There are more than 100 distinct sorts of cancer and each is ordered by the kind of cell which is first influenced. Malignancy is thought to be one of the main sources of grimness and mortality around the world. More than 575,000 individuals bite the dust of tumor and more than 1.5 million individuals are determined to have disease every year in the US. A restorative expert who hones in the field of cancer and cancer related diseases is an oncologist.

In addition to the multidisciplinary talks, keynote sessions and lectures relevant to cancer science & therapy, the Cancer Therapy 2018 is a complete 2 days event with panel discussions, open Q & A to generate a prime learning knowledge between participants.

Scientific Session of the Conference includes:

• Target Therapy

• Cancer Immunotherapy & Vaccines

• Cancer Metabolism

• Cancer Epigenomics

• Cancer Inflammation and Immune Tolerance

• Nanoparticles in Cancer Therapy

• Novel Approaches to Cancer Therapeutics

• Cancer Management & Prevention

• Cancer Pharmacology

• Tumor Virology

• Tumour immunology & immunotherapy

• Organ-Specific Cancer

• Cancer Biomarkers

• Cancer Stem Cell Therapy

• Anti-Cancer Agents in Medicinal Chemistry

• Surgical Oncology

• Cancer: Psychological & Social Aspects

• Radiation Oncology

• Cancer Chemotherapy

• Cancer Diagnostics & Diagnostic Market

• Complementary and Alternative Cancer Treatment

• Medical Oncology

• Mechanisms of Carcinogenesis

• Genetic Cancer Susceptibility

• Infections and Cancer Epidemiology

• Etiology of Cancer

• Cancer Treatment Research

• Cancer Genetics and genomics

• Computational Oncology

• Solid Tumour Oncogenesis

1. Target Therapy

Targeted therapy is a special type of chemotherapy involves a mechanism of differentiating between cancerous and non-cancerous cells in the body, attacking only the cancerous ones but not interfering with the normal ones. it is sometimes used alone, but most often other cancer treatments are used in combination with targeted therapy.

• Therapeutic Monoclonal Antibodies
• Small Molecule Drugs
• Tyrosine-kinase inhibitors
• Implications of Targeted Therapy
• Targeted Cancer Therapy & Health Economics
• Hormone Therapies

2. Cancer Immunotherapy & Vaccines

Cancer immunotherapy (Immuno-oncology or Immunooncology) is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These approaches exploit the fact that cancer cells often have molecules on their surface that can be detected by the immune system, known as tumour-associated antigens (TAAs); they are often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the immune system to attack tumor cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

• Nano systems
• Targeted delivery
• Cell tracking
• Immunotherapy
• Tumor biology
• Cancer vaccines

3. Cancer Metabolism

Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most normal tissue cells. Metabolic alterations in cancer cells are numerous and include aerobic glycolysis, reduced oxidative phosphorylation and the increased generation of biosynthetic intermediates needed for cell growth and proliferation.

4. Cancer Epigenomics

Cancer epigenetics is the study of epigenetic modifications to the genome of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic alterations are as important as genetic mutations behind the transition of a cell from normal to cancerous, and their manipulation holds great promise for cancer prevention, detection and therapy. In different types of cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications and dysregulation of DNA binding proteins.

• Cancer genomics
• Epigenetic influence on genomic stability
• Molecular underpinnings of therapeutic targets
• Aberrant DNA methylation genes
• Tumor heterogeneity

5. Cancer Inflammation and Immune Tolerance

It is widely accepted that chronic inflammation critically contributes to cancer. Immune tolerance in cancer mediates tumor escape from the immune system. Inflammation mediates tumor-induced tolerance. The induction and the maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.

6. Nanoparticles in Cancer Therapy

Nanoparticles have been of significant interest over the last decade as they offer great benefits in drug delivery to overcome limitations present in case of conventional chemotherapy. They can not only be formed in a range of sizes (1-1000 nm) but also made by using a variety of materials including polymers, lipids, inorganic materials and biological materials. Using targeted nanoparticles to deliver chemotherapeutic agents in cancer therapy, offers many advantages to improve drug/gene delivery and to overcome many problems associated with conventional chemotherapy.

7. Novel Approaches to Cancer Therapeutics

The normal treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment.

• Cancer Epigenetics
• Molecular Profiling Techniques
• New Biologics & Vaccines
• Chemical Proteomics
• Combination Strategies in Immuno-oncology
• Novel Biomarker Discovery

8. Cancer Management & Prevention

Types of Cancer which are closely linked to certain behaviours are the easiest to prevent. Many complementary health approaches are also found to combat the risks associated with cancer like, for example, herbal and other dietary supplements, acupuncture, massage and yoga.

• Lifestyle changes
• Diet & Cancer
• Vaccinations
• Natural Therapy
• Psychological & Social Aspects

9. Cancer Pharmacology

Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

10. Tumor Virology

Since its inception, the field of tumor virology has provided ground-breaking insights into the causes of human cancer. Tumor virologists additionally recognized that viruses could serve as powerful discovery tools, leading to revolutionary breakthroughs in the 1970s and 1980s that included the concept of the oncogene, the identification of the p53 tumor suppressor, and the function of the retinoblastoma tumor suppressor. This rich history promises that tumor virology will continue to contribute to our understanding of cancer and to the development of new therapeutic and preventive measures for this disease

11. Tumour immunology & immunotherapy

Tumor Immunology and Immunotherapy focuses on recent advances in understanding the range of immune responses towards cancer and how these can be modified and harnessed for prevention and therapeutics.

12. Organ-Specific Cancer

Malignancy has a differentiated nature in connection to the organ specificity. The essential focus is on heterogeneity, starting point, metastasis, angiogenesis and organ indicated systems in disease cells. There is a diverse spectrum of diseases, taking into account the area of tumor in the body organ. Organ-particular metastasis includes disease cell collaborations with the host micro-environment, including actuation of paracrine cytokine circles, change of the host cell synthesis, and modification of extracellular framework structures.

13. Cancer Biomarkers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected bio-fluids like blood or serum.

• Imaging Biomarkers
• Clinical Biomarkers
• Genetic Biomarkers
• Predictive Cancer Biomarkers
• Molecular Biomarkers
• Cell Free Biomarkers

14. Cancer Stem Cell Therapy

Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers. Blood-forming stem cells are important because they grow into different types of blood cells.

• Cancer Stem Cells
• Stem Cells and Tumors
• Stem Cell Transplantation
• Bone Marrow Transplantation
• Cord Blood Stem Cells and Cancer
• Stem Cell Research

15. Anti-Cancer Agents in Medicinal Chemistry

Anti-Cancer agents in Medicinal Chemistry aim to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

16. Surgical Oncology

Surgical oncology is a specialty that focuses on the surgical treatment of a variety of tumors. Ephraim McDowell did the first reported resection of an ovarian tumor in 1809, but as early as the 7th century, ancient Egyptians described techniques for removing breast tumors.

17. Cancer: Psychological & Social Aspects

Cancer treatments today are likely to cause less physical deformity from surgery than a half-century ago, but are more complex and extend over a longer period of time. People today are often well informed about the details of their cancer diagnosis and prognosis, and are increasingly involved in shared decision-making regarding treatment. Although serious depression is not seen in the majority of cancer patients and survivors, many will experience treatment-related distress, fear of recurrence, changes in body image and sexuality, as well as physical toxicities that result from adjuvant therapy. It is important to identify the psychological and social concerns of cancer patients in the medical setting, and assisting them in obtaining appropriate psychosocial services.

18. Radiation Oncology

Radiation oncology is a medical speciality that involves the controlled use of radiation to treat cancer either for cure, or to reduce pain and other symptoms caused by cancer. Radiation therapy (also called radiotherapy) is the term used to describe the actual treatment delivered by the radiation oncology team.

19. Cancer Chemotherapy

The word chemotherapy means drugs used for cancer treatment. It’s often shortened to “chemo.” Surgery and radiation therapy remove, kill, or damage cancer cells in a certain area, but chemo can work throughout the whole body. This means chemo can kill cancer cells that have spread (metastasized) to parts of the body far away from the original (primary) tumor.

20. Cancer Diagnostics & Diagnostic Market

Cancer diagnostics market is witnessing high growth due to increasing prevalence and incidences of several types of cancers. Major drivers for the global cancer diagnostic market are technologically advanced and increasing point-of-care diagnostics, cost-effective treatment modalities and personalized medicine. Additionally, increasing persistence to provide best-in-class healthcare services with high accuracy and efficiency towards patient is expected to fuel the global cancer diagnostics market across the globe.

21. Complementary and Alternative Cancer Treatment

Alternative cancer treatments may not play a direct role in curing the cancer, but they may help in coping up with the signs and symptoms caused by cancer and cancer treatments. CAM (Complementary and Alternative Medicine) is the term for medical products and practices that are not part of standard care.Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you receive from your doctor may help relieve many of the symptoms associated with cancer and its treatment.

22. Medical Oncology

Alternative cancer treatments may not play a direct role in curing the cancer, but they may help in coping up with the signs and symptoms caused by cancer and cancer treatments. CAM (Complementary and Alternative Medicine) is the term for medical products and practices that are not part of standard care.Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you receive from your doctor may help relieve many of the symptoms associated with cancer and its treatment.

23. Mechanisms of Carcinogenesis

Carcinogenesis, also called oncogenesis or tumorigenesis, is the mechanism of formation of a cancer, where normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division.

24. Genetic Cancer Susceptibility

Carcinogenesis, also called oncogenesis or tumorigenesis, is the mechanism of formation of a cancer, where normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division.

25. Infections and Cancer Epidemiology

As persistent infection with viruses, bacteria, or parasites is a predominant cause of human cancer, notably in low- and middle-income countries, Infections and Cancer Epidemiology contributes substantially to IARC′s mission of cancer prevention in the most vulnerable populations.

26. Etiology of Cancer

The Infections and Cancer Epidemiology Group (ICE) has estimated that approximately 2 million cancer cases worldwide can be attributed to infectious agents. Promoting human papillomavirus (HPV) vaccination and cervical screening programmes for the prevention of cervical cancer is an ICE priority. However, other associations between infectious agents and cancer require additional research and better standardized control measures.

27. Cancer Treatment Research

Cancer treatments that target the specific changes, most often in proteins, that underlie the growth and development of cancer. Surgery, radiation therapy, and standard chemotherapy will continue to play an important role in treating cancer, but the emergence of targeted therapies and of immunotherapies,in the recent years, which harness the power of the immune system to fight cancer, have expanded the treatment options available to patients with certain types of cancer.

28. Cancer Genetics and genomics

The Cancer Genetics and Genomics (CGG) Program serves to coordinate the research activities related to the study and understanding of cancer genomics, epigenetics, gene expression, model systems and host interactions. The CGG is at the forefront of applying 'omics' technologies that assess alterations in cancer genomes, epigenomes and transcriptomes, or techniques that are capable of editing the genome or epigenome of a model system. The program serves as the primary source of expertise for these aspects of cancer.

• Tumor cell proliferation
• Genetic Studies
• The Cancer Genome Atlas (TCGA)
• Genetic Tools
• Metabolic Technologies
• Data Interpretations

29. Computational Oncology

The field of computational oncology has forged a new relationship between the physical sciences and oncology to further advance research. By applying physics and mathematics to oncologic problems, new insights will emerge into the pathogenesis and treatment of malignancies. One major area of investigation in computational oncology centres around the acquisition and analysis of data, using improved computing hardware and software. Large databases of cellular pathways are being analyzed to understand the interrelationship amongst complex biological processes.

30. Solid Tumour Oncogenesis

Oncogene amplifications have been shown in solid human cancers and they are often associated with progression of cancer. Defining oncogene amplification is useful since it is used as a prognostic marker in clinical oncology nowadays, especially v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (HER2) targeted agents are used in breast cancer patients with high level of HER2 overexpression as a therapeutic approach.

 
 
 
 
 
 
 
 
 
 
 
 

Past Conference Report

Cancer Therapy 2017

The 25th World Congress on Cancer Science and Therapy 2017 was held at Baltimore during October 18-20, 2017.

The conference focused on Cancer Science and Therapy Medicine studies with the theme ‘Characterizing Novel Approaches in Diagnosis and Cancer Therapies”. The meeting was engrossed in a rich diversified spectrum of comprehensive discussions on novel subjects like Cancer Therapy and Cancer Genetics, Cancer Cell Biology, Stem Cell Therapy, Immunotherapy, Cancer Biomarkers, Novel Approaches to Cancer Therapeutics, Childhood cancer and developmental stages, Cancer Management & Prevention, Targeted Cancer Therapy, Precision Medicine & Cancer Therapy, Cancer: Psychological & Social Aspects, Complementary and Alternative Cancer Treatment, Cancer Case Reports, Cellular and Technological Breakthroughs in Cancer, and Cancer Diagnostics & Diagnostic Market.

The conference embarked with the opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

• Frédéric Baribaud, Johnson & Johnson, USA
• Yoshiaki Omura, New York Medical College, USA
• Diana Anderson, University of Bradford, UK
• Jianhua Luo, University of Pittsburgh, USA
• Michael Retsky, Harvard School of Public Health, USA
• Sherry A Bradford, AccuTheranostics, USA
• Xichun Sun, Virginia Commonwealth University, USA
• Lowe Leroy, Lancaster University, UK
• Melvin L DePamphilis, National Institute for Child Health & Human Development, USA
• George Vasmatzise, Mayo Clinic, USA

Conference Series Ltd offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference Series Ltd and supported the conference in every aspect, without which the conference would not have been possible.

Your reunion is our inspiration; keeping this motto in mind and having witnessed the triumph of Cancer Science and Therapy 2017, Conference Series Ltd would like to announce the commencement of the “26th Annual Congress on Cancer Science and Therapy” to be held during October 03-04, 2018 Los Angeles, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness some invaluable scientific discussions and contribute to the future innovations in the field of Cancer Science and Therapy Research.

For More details: http://cancer.global-summit.com/america/

 

Let us meet again @ Cancer Science and Therapy 2018

 
 

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date October 29-30, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Cancer Science & Therapy Journal of Carcinogenesis & Mutagenesis Journal of Integrative Oncology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Adrenocortical Carcinoma
  • Bone Cancer
  • Brain Tumor Therapy
  • Cancer Biomarkers
  • Cancer Diagnosis
  • Cancer Disparities
  • Cancer Epidemiology
  • Cancer Etiology
  • Cancer Metastasis
  • Cancer Mortality
  • Cancer Oncogenes
  • Cancer Statistics
  • Carcinogenesis
  • Carcinoid Tumor
  • Chemotherapy
  • Clinical Cancer Research
  • Colorectal Cancer
  • Embryonal Tumors
  • Endometrial Cancer 
  • Ependymoma- Chilhood
  • Ewing Sarcoma
  • Gardner Syndrome
  • Gastrointestinal Carcinoid Tumor
  • Gene Cancer Therapy
  • Genes And Cancer
  • Germ Cell Tumours
  • Haematological Oncology
  • Hereditary Cancers
  • Hormone Therapy
  • Immunotherapy
  • Laryngeal Cancer 
  • Localized Cancer
  • Lymphoma 
  • Malignant Tumors
  • Merkel Cell Carcinoma
  • Parathyroid Cancer
  • Precision Medicine In Cancer Treatment
  • Radiation Therapy
  • Stem Cell Transplant
  • Surgical Oncology
  • Targeted Therapy
  • Tumor Markers
  • Tumour Biology
  • Tumour Suppressor Genes
  • Vascular Tumors